Many healthcare stocks' earnings reports lately include the phrases "inflationary pressures," "labor shortages," "supply chain issues," and "short-term macroeconomic conditions" to describe why earnings are flat or down.

The S&P 500 index is down more than 20% so far this year and even the healthcare sector, which is considered non-cyclical and somewhat recession-proof, is down more than 7% in 2022.

That's not the case with all healthcare stocks, though. UnitedHealth Group (NYSE: UNH), AbbVie (NYSE: ABBV), and Vertex Pharmaceuticals (NASDAQ: VRTX) are all up 8.5% or more this year despite the headwinds affecting so many companies.

Continue reading

Source Fool.com